Daye
PrivateLast Round
Series A
Oct 26, 2022
Total Funding Raised
$17.12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Daye operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in October 2022.
Daye is a gynecological health company that develops innovative products and services, including CBD-infused tampons and at-home diagnostic testing kits, to address gaps in women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Biotechnology, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Daye Comparables
Compare Daye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evvy | 85% | |
| Hertility | 83% | |
| Hormona | 79% |
For institutional investors. Book with your work email.
Daye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 26, 2022 | ||||
| Seed | May 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Daye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Salica Investments | Series A |
| Khosla Ventures | Series A, Seed |
| Gaingels | Series A |
| Kindred Capital | Seed |
| Cross Border Impact Ventures | Series A |
| Index Ventures | Seed |
| MassMutual Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2025
Launched 'Hormonal Testing from Home' service.
- Nov 5, 2025
Over 100,000 users now trust their products.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 16, 2026
On Oct 16th '26 in United Kingdom, Daye Limited and Sapyen announce an exclusive partnership that lets customers, telehealth partners, and clinics order male fertility and vaginal health tests from either company.
For institutional investors. Book with your work email.
Daye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Daye's valuation, stock price, and market status.
Is Daye a public or private company?
Daye is a private company.
What is the current stock price of Daye?
Daye is a private company, so its shares have no public market price. Caplight tracks Daye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Daye worth (valuation)?
Valuation information for Daye is not publicly available.
Can I buy Daye stock?
Daye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Daye's last funding round?
Daye's most recent funding round was Series A on October 26, 2022.
Who are the main investors in Daye?
Key investors in Daye include Salica Investments, Index Ventures, MassMutual Ventures, Hambro Perks Ltd..
Will Daye IPO soon?
No public IPO plans have been announced for Daye.
How can I track Daye secondary market activity?
Caplight tracks bids, offers, and trades in Daye's shares on secondary markets.